Comparison of three and four- field radiotherapy technique and the effect of laryngeal shield on vocal and spinal cord radiation dose in radiotherapy of non-laryngeal head and neck tumors

• Autorzy: Pour N. H. , Farajollahi A. , Jamali M. , Zeinali A. , Jangjou A. G.

Identyfikatory

DOI

10.2478/pjmpe-2018-0004

• Języki publikacji: EN

Abstrakty

EN

Introduction: Due to the effect of radiation on both the tumor and the surrounding normal tissues, the side effects of radiation in normal tissues are expected. One of the important complications in the head and neck radiotherapy is the doses reached to the larynx and spinal cord of patients with non-laryngeal head and neck tumors. Materials and Methods: In this study, CT scan images of 25 patients with non-laryngeal tumors including; lymph nodes, tongue, oropharynx and nasopharynx were used. A three-field and a four-field treatment planning with and without laryngeal shield in 3D CRT technique were planned for each patient. Subsequently, the values of Dmin, Dmean, Dmax and Dose Volume Histogram from the treatment planning system and NTCP values of spinal cord and larynx were calculated with BIOPLAN and MATLAB software for all patients. Results: Statistical results showed that mean values of doses of larynx in both three and four-field methods were significantly different between with and without shield groups. Comparison of absorbed dose didn’t show any difference between the three and four field methods (P>0.05). Using Shield, just the mean and minimum doses of spinal cord decreased in both three and four fields. The NTCP of the spinal cord and larynx by three and four-field methods with shield in the LKB and EUD models significantly are less than that of the three and four fields without shields, and in the four-field method NTCP of larynx is less than three radiation field. Conclusion: The results of this study indicate that there is no significant difference in doses reached to larynx and spinal cord between the treatments techniques, but laryngeal shield reduce dose and NTCP values in larynx considerably.

Słowa kluczowe

EN

3D CRT; larynx; spinal cord; DVH; NTCP

• Wydawca: Polskie Towarzystwo Fizyki Medycznej ; De Gruyter
• Czasopismo: Polish Journal of Medical Physics and Engineering
• Rocznik: 2018
• Tom: Vol. 24, Iss. 1
• Strony: 25--31
• Opis fizyczny: Bibliogr. 40 poz., rys., tab.

Twórcy

autor

Pour N. H.

• Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
• Department of Medical Physic, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran

autor

Farajollahi A.

• Medical Education Research Center, Tabriz, Iran
• Department of Medical Physic, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran
• Imam Reza University Hospital, Radiotherapy Department, Tabriz University of Medical Science, Tabriz, Iran

autor

Jamali M.

• Radiotherapy Center of Omid Hospital, Urmia, Iran

autor

Zeinali A.

• Department of Medical Physic, Urmia University of Medical Science, Urmia, Iran

autor

Jangjou A. G.

• Imam Reza University Hospital, Radiotherapy Department, Tabriz University of Medical Science, Tabriz, Iran

Bibliografia

• [1] Peszynska-Piorun M, Malicki J, Golusinski W. Doses in organs at risk during head and neck radiotherapy using IMRT and 3D-CRT. Radiol Oncol; 2012;46(4):328-336.
• [2] Yeh SA. Radiotherapy for Head and Neck Cancer. Semin Plast Surg. 2010; 24(2):127-136.
• [3] Putipun Puataweepong. Advanced Radiation Therapy for Head and Neck Cancer: A New Standard of Practice. Ramathibodi Hospital, Mahidol UniversityThailand.
• [4] Bakiu E, Telhaj E, Kozma E, et al. Comparison of 3D CRT and IMRT Tratment Plans. Acta Inform Med. 2013;21(3):211-212.
• [5] Molazadeh M, Saberi H, Rahmatnezhadi L, et al. Evaluation the Effect of Photon Beam Energies on Organ at Risk Doses in Three-Dimensional Conformal Radiation Therapy. Res J Appl Sci Eng Technol. 2013;6(12):2110-2117.
• [6] Intensity Modulated Radiation Therapy. Irsa.org. Retrieved 2012-04-20.
• [7] Herman TF, Schnell E, Young J, et al. Dosimetric comparison between IMRT delivery modes: Step-and-shoot, sliding window, and volumetric modulated arc therapy - for whole pelvis radiation therapy of intermediate-to-high risk prostate adenocarcinoma. J Med. Phys. 2013;38(4):165-72.
• [8] Herrassi MY, Bentayeb F, Malisan MR. Comparative study of four advanced 3d-conformal radiation therapy treatment planning techniques for head and neck cancer. J Med Phys. 2013;38(2):98-105.
• [9] Fung K, Yoo J, Leeper HA, et al. Effects of head and neck radiation therapy on vocal function. J Otolaryngol. 2001;30(3):133-139.
• [10] Breen S, Craig T, Bayley A, et al. Spinal cord planning risk volumes for intensity-modulated radiation therapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;64(1):321-325.
• [11] Schultheiss TE, Kun LE, Ang KK, et al. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys. 1995;31(5):1093-1112.
• [12] Emami B. Tolerance of Normal Tissue to Therapeutic Radiation. Rep Radiother Oncol. 2013;1(1):35-48.
• [13] Lukarski D, Krstevska V, Petkovska S. A Treatment Planning Comparison of Two Different 3D Conformal Technique for Irradiation of head and neck cancer patients, Proceedings of the Second Conference on Medical Physics and Biomedical Engineering.
• [14] Nguyen NP, Ceizyk M, Vos P, et al. Effectiveness of image-guided radiotherapy for laryngeal sparing in head and neck cancer. Oral Oncol. 2010;46(4):283-286.
• [15] Hamdan A, Geara F, Rameh C, et al. Vocal changes following radiotherapy to the head and neck for non-laryngeal tumors. Eur Arch Otorhinolaryngol. 2009;266(9):1435-1439.
• [16] Rancati T, Schwarz M, Allen AM. Radiation dose-volume effects in larynx and pharynx. Int J Radiat Oncol Biol Phys. 2010;76(3Suppl):S64-S69.
• [17] Paulino AC, Arceci RJ. Nasopharyngeal Cancer Treatment & Management. https://emedicine.medscape.com/article/988165-treatment. 2015.
• [18] Grégoire V, de Neve W, Eisbruch A, et al. Intensity-Modulated Radiation Therapy for Head and Neck Carcinoma. Oncologist. 2007;12(5):555-564.
• [19] Sanchez-Neito B, Nahum AE. BIOPLAN: software for the biological evaluation of radiotherapy treatment plans. Med Dosim. 2000;25(2):71-76.
• [20] Kallman P, Agren A, Brahme A. Tumor and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol. 1992; 62(2):249-262.
• [21] Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21(1):123-135.
• [22] Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109-122.
• [23] Jones B, Dale R. Mathematical models of tumor and normal tissue response. Acta Oncol. 1999;38(7):883-893.
• [24] Rancati T, Fiorino C, Sanguineti G. NTCP modeling of sub-acute/late laryngeal edema scored by fiberopitic examination. Int J Radiat Oncol Biol Phys. 2009;75(30):915-923.
• [25] Niemierko A. Goitein M. Modeling of normal tissue response to radiation: the critical volume model. Int J Radiat Oncol Biol Phys. 1993;25(1):135-145.
• [26] Luxton G, Keall PJ King CR. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD). Phys Med Biol. 2008;53(1):23-36.
• [27] Gay HA, Niemierko A. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. Phys Med. 2007;23(3-4):115-125.
• [28] Allen LX, Alber M, Deasy JO, et al. The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys. 2012;39(3):1386-1409.
• [29] Oinam AS, Singh L, Shukla A, et al. Dose volume histogram analysis and comparison of different radiobiological models using in-house developed software. J Med Phys .2011;36(4):220-229.
• [30] Gomez D, Cahlon O, Mechalakos J, et al. An investigation of intensity modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer. Radiat Oncol. 2010;5:74.
• [31] Varadharajan E, Swaminathan S, et al. Biological evaluation of 3D conformal radiotherapy and intensity modulated radiotherapy plans in different clinical situations. JIPMER Journal of cancer. 2014;3(1):35-43.
• [32] Eisbruch A, Schwarz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT. Int J Radiat Oncol Biol Phys. 2004;60(5):1425-1439.
• [33] Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose–effect relationships for the swallowing structures .Int J Radiat Oncol Biol Phys. 2007;68(5):1289-1299.
• [34] Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother Oncol. 2007;85(1):74-82.
• [35] Caglar HB, Allen AM, Othus M, et al. Dose to the larynx predicts for swallowing complications following IMRT and chemotherapy. Int J Radiat Oncol Biol Phys. 2007;69:(Suppl. 1):S53–S54.
• [36] Kristensen CA, Kjær-Kristoffersen F, Sapru W, et al. Nasopharyngeal carcinoma Treatment planning with IMRT and 3D conformal radiotherapy. Acta Oncol. 2007;46(2):214-220.
• [37] Kan MW, Leung LH, Yu PK. The use of biologically related model (Eclipse) for the intensity-modulated radiation therapy planning of nasopharyngeal carcinoma. PLoS One. 2014;9(11):e112229.
• [38] Boughalia A, Marcie S, Fellah M, et al. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP). Br J Radiol. 2015;88(1050):20140839.
• [39] Kam MK, Chau RM, Suen J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys. 2003;56(1):145-147.
• [40] Moiseenko V, Battista J, Van DJ. Normal tissue complication probabilities (dependence on choice of biological model and dose-volume histogram reduction scheme). Int J Radiat Oncol Biol Phys. 2000;46(4):983-993.